Your browser doesn't support javascript.
loading
Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas.
Acciardo, Stefania; Mignion, Lionel; Joudiou, Nicolas; Bouzin, Caroline; Baurain, Jean-François; Gallez, Bernard; Jordan, Bénédicte F.
Afiliación
  • Acciardo S; Université Catholique de Louvain, Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Brussels, Belgium.
  • Mignion L; Université Catholique de Louvain, Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Brussels, Belgium.
  • Joudiou N; Université Catholique de Louvain, Louvain Drug Research Institute, NEST Nuclear and Electron Spin Technologies Platform, Brussels, Belgium.
  • Bouzin C; Université Catholique de Louvain, Institute de Recherche Expérimentale et Clinique, IREC Imaging Platform, Brussels, Belgium.
  • Baurain JF; Université Catholique de Louvain, Institute de Recherche Expérimentale et Clinique, Molecular Imaging and Radiation Oncology Group, Brussels, Belgium.
  • Gallez B; Université Catholique de Louvain, Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Brussels, Belgium.
  • Jordan BF; Université Catholique de Louvain, Louvain Drug Research Institute, Biomedical Magnetic Resonance Group, Brussels, Belgium.
Oncotarget ; 9(24): 16832-16846, 2018 Mar 30.
Article en En | MEDLINE | ID: mdl-29682188
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article